Eka Ventures is an early-stage venture fund integrating impact investing into mainstream venture capital by backing sustainable and health-focused consumer businesses.
The round was led by We Venture Capital and Cross-Border Impact Ventures to support the development of liquid biopsy tests.
"The power of the OXcan proteomics biomarker discovery platform and the data generated by Oxcan stand out against the backdrop of other liquid biopsy companies, indicating a truly superior performance in the identification of early stage lung cancer"
The round was led by We Venture Capital and Cross-Border Impact Ventures to fund the global commercialisation of its liquid biopsy technology.
"Having developed blood-based proteomic tests for lung cancer for over two decades, I appreciate the difficulty of detecting cancers early through liquid biopsy. Convinced that OXcan’s unique approach can address this clinical need, I feel privileged to join the team. Together, our plan is to offer this novel technological approach to large markets worldwide to start a new era of early detection and improve patient outcomes."
— Heinrich Roder, Senior Vice President of Research and Development
Accel led the seed round with participation from Picus Capital, Eka Ventures, and notable angels to fund team expansion and market growth.
"Karl and Archy have a wealth of experience in the energy sector, and their vision for rebuilding the grid in favour of renewable energy sources is truly exciting – and necessary. They’ve seen strong early traction, with their easy-to-use software platform already being used by major manufacturers. We’re proud to back Axle Energy as they continue this growth."
The oversubscribed round was led by Heartcore Capital with backing from Eka Ventures and angel investors.
"It was a delight to experience such overwhelming interest from investors enthusiastic about the future of flight-free travel when raising our Series A. I’m thrilled that in Heartcore and Eka we’ve found partners who believe in the joy of journey-based holidays and the potential of JourneyAI to change travel for the better,"
JamJar leads the £5m round to help the running coaching application develop artificial intelligence capabilities.
"I felt a huge sense of privilege to get to work with up to 40 private clients at a time before launching Runna, helping them to be healthier and happier. Now having been able to build a service to deliver a better experience, at a tenth of the price, to over 50 thousand people is hard to get my head around."